![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 09, 2010 9:50:15 PM
"Regenetech started producing revenue only 5 years after its founding, and since acquiring the original NASA licenses, it has developed over 300 of its own patents and patent applications and has licensed out its technologies on a global scale. The company generates its revenue through research partnerships and licensing its patents to stem cell researchers in pursuit of treatments for everything from heart disease to diabetes to liver cirrhosis. It is currently engaged in sponsored research agreements with major universities to develop stem cell therapy for type 1 diabetes, study blood stem cells, and create stem cell veterinary orthopedic treatments using the company’s Intrifuge cellXpansion technology."
Recent EUBG News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:02:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 09:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:02:50 PM
- Form SPDSCL - SEC Specialized Disclosure • Edgar (US Regulatory) • 07/20/2023 04:55:56 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM